Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Boston Life Sciences begins preclinical program for ophthalmic indications of antiangiogenic product

July 18, 1997

New insights into glaucoma and implications for drug therapy

July 15, 1997

Prostaglandins in early development at Allergan for glaucoma

July 4, 1997

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

June 27, 1997

Genistein prevents ischemic retinal degeneration in rats

June 25, 1997

Merck & Co. discloses muscarinic antagonists for myopia

June 20, 1997

Agents for glaucoma revealed by Merck & Co.

June 20, 1997

AEterna's IND for Neoretna approved in Canada

June 16, 1997

Retinal protein reduces need for standard drugs in uveitis

June 10, 1997

Oculex and Storz sign marketing agreement for ocular product

June 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...